25.07.2016
Acino divests its patch business to Luye Pharma Group Ltd.
Today Acino International AG and Acino Pharma AG (together “Acino”) have signed a definitive agreement with Luye Pharma Group Ltd....
News
Growth
13.07.2016
Acino to acquire Takeda’s manufacturing plant in Põlva, Estonia
Acino and Takeda announced today that Acino will acquire Takeda’s manufacturing site in Põlva, Estonia.The packaging site in Estonia is...
28.06.2016
Acino acquires the Middle East and North Africa (MENA) operations and product rights from Norgine B.V.
Acino today announced that it has completed the acquisition of the MENA operations and product rights for MOVICOL®, MOVIPREP®, KLEAN-PREP® and...
07.10.2015
Acino continues expanding its emerging markets business by acquiring Pharma Start
Effective October 1, 2015, Acino Pharma, an international pharmaceutical company headquartered in Switzerland, acquires Pharma Start, the 9th largest local...
04.09.2015
Acino launches the first generic Rivastigmine patch in the USA
Acino’s rivastigmine patch is the first generic alternative to the originator product making the medical treatment of Alzheimer’s more affordable...
17.02.2015
Acino welcomes German court ruling on rivastigmine
Acino announces the achievement of another judicial success in the ongoing German intellectual property litigation proceedings regarding its generic rivastigmine...
06.11.2014
Acino receives Frost & Sullivan Award for Enabling Technology Leadership
Acino is proud to be the recipient of the Frost & Sullivan “2014 European Pharmaceutical Drug Delivery Enabling Technology Leadership...
07.07.2014
Cancellation of the remaining publicly held registered shares of Acino Holding AG
With decision dated June 26, 2014, the Cantonal court of Basel-Landschaft has admitted the claim of Pharma Strategy Partners GmbH,...
23.01.2014
Acino: Publicity Duties
After the successful completion of the tender offer of Pharma Strategy Partners for Acino Holding AG (Acino), SIX Exchange Regulation...